The already reported monomeric complex Co(SDZ)2bpy (1) and the new ternary complex Co(SDZ)2(6MQ)2 (2) (SDZ = sulfadiazine, bpy = 2,2′‐bipyridine, and 6MQ = 6‐methoxyquinoline) have been synthesized in order to study their magnetic properties. X‐ray diffraction studies indicate that in both compounds the SDZ acts as a bidentate ligand coordinating through the sulfonamide and the pyrimidine N atoms giving rise to a CoN6 coordination sphere. The complexes have been characterized based on elemental analyses, FTIR, UV/Vis spectroscopy, and thermogravimetric analysis (TGA, only for 2). Compounds 1 and 2 have been characterized magnetically, and they show slow relaxation of the magnetization below 9 and 6 K, respectively.
Five complexes with 6-methoxyquinoline have been synthesized; their structural, spectroscopic, photophysical and biological properties have been studied.
A new complex of Hg(II) with 6-methoxyquinoline (C 10 H 9 NO-6MQ) has been synthesized and characterized. The structure of the complex Hg(6MQ)Cl 2 was determined by single crystal X-ray diffraction. It crystallizes in the monoclinic space group P2 1 /c with a = 3.9139(3), b = 26.3400(2), c = 10.9090(9) Å, β = 89.833(6)°, V = 1124.6(1) Å 3 and Z = 4 molecules per unit cell. The coordination geometry of the mercury(II) center can be described as a distorted square pyramid formed by one nitrogen atom of the 6MQ and four chlorine atoms. Fourier transform infrared, Raman and UV/Vis spectroscopic studies have been carried out to characterize the compound, using theoretical calculations for the assignment of the experimentally observed bands. The thermal behavior was investigated by thermogravimetric analysis. The quantum yield of singlet molecular oxygen production Φ Δ was measured with steady-state methods in ethanol, using 9,10-dimethylanthracene (DMA) as actinometer and Bengal rose as reference photosensitizer. The resultant singlet molecular oxygen was detected indirectly by photooxidation reactions of DMA. The luminescence properties have also been studied.
Three ternary complexes with sulfaquinoxaline or sulfamethazine have been synthesized and their structural, spectroscopic and biological properties have been studied.
The aim of this work was to study the antitumor effects and the mechanisms of toxic action of a series of 6-methoxyquinoline (6MQ) complexes in vitro. The Cu(II) and Zn(II) complexes (Cu6MQ and Zn6MQ) are formulated as M(6MQ) 2 Cl 2 ; the Co(II) and Ag(I) compounds (Co6MQ and Ag6MQ) are ionic with formulae [Ag(6MQ) 2 ] + NO 3 − and H(6MQ) + [Co(6MQ) Cl 3 ] − (where H(6MQ) + is the protonated ligand). We found that the copper complex, outperformed the Co(II), Zn(II) and Ag(I) complexes with a lower IC 50 (57.9 µM) in A549 cells exposed for 24 h. Cu6MQ decreased cell proliferation and induced oxidative stress detected with H 2 DCFDA at 40 µM, which reduces GSH/GSSG ratio. This redox imbalance induced oxidative DNA damage revealed by the Micronucleus test and the Comet assay, which turned into a cell cycle arrest at G2/M phase and induced apoptosis. In multicellular spheroids, the IC 50 values tripled the monolayer model (187.3 µM for 24 h). At this concentration, the proportion of live/dead cells diminished, and the spheroids could not proliferate or invade. Although Zn6MQ also decreased GSH/GSSG ratio from 200 µM and the cytotoxicity is related to oxidative stress, the induction of the hydrogen peroxide levels only doubled the control value. Zn6MQ induced S phase arrest, which relates with the increased micronucleus frequency and with the induction of necrosis. Finally, our results reveal a synergistic activity with a 1:1 ratio of both complexes in the monolayer and multicellular spheroids.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.